 |
InterPro: IPR001357 BRCT
Example proteins
|
O00541 Pescadillo homolog
P09838 DNA nucleotidylexotransferase
P11938 DNA-binding protein RAP1
P35600 Replication factor C subunit 1
P41882 Ankyrin repeat-containing protein F37A4.4
More proteins
Example Proteins Key
| InterPro entry accession number/name and structure databases |
Colour code |
| IPR002054 |
DNA-directed DNA polymerase, family X |
 |
| IPR014778 |
Myb, DNA-binding |
 |
| IPR013725 |
DNA replication factor RFC1, C-terminal |
 |
| IPR012287 |
Homeodomain-related |
 |
| IPR012178 |
DNA replication factor C, large subunit |
 |
| IPR001005 |
SANT, DNA-binding |
 |
| IPR002110 |
Ankyrin repeat |
 |
| IPR001357 |
BRCT |
 |
| IPR019843 |
DNA polymerase family X, binding site |
 |
| IPR003125 |
Protein of unknown function WSN |
 |
| IPR003959 |
ATPase, AAA-type, core |
 |
| IPR010996 |
DNA-directed DNA polymerase, family X, beta-like, N-terminal |
 |
| IPR002934 |
Nucleotidyltransferase |
 |
| IPR003593 |
ATPase, AAA+ type, core |
 |
| IPR008921 |
DNA polymerase III, clamp loader complex, gamma/delta/delta subunit, C-terminal |
 |
| IPR017930 |
HTH transcriptional regulator, Myb-type, DNA-binding |
 |
| IPR020683 |
Ankyrin repeat-containing domain |
 |
| IPR001726 |
DNA nucleotidylexotransferase |
 |
| IPR015280 |
Rap1, DNA-binding |
 |
| IPR018944 |
DNA polymerase lambda, fingers domain |
 |
| IPR010613 |
Pescadillo, N-terminal |
 |
| IPR009057 |
Homeodomain-like |
 |
|
ModBase |
 |
|
SWISS-MODEL |
 |
|
PDB Chain |
 |
|
CATH Domain |
 |
|
SCOP Domain |
 |
|
Additional Reading
|
|
Oishi H, Kitagawa H, Wada O, Takezawa S, Tora L, Kouzu-Fujita M, Takada I, Yano T, Yanagisawa J, Kato S.
An hGCN5/TRRAP histone acetyltransferase complex co-activates BRCA1 transactivation function through histone modification.
J. Biol. Chem. 281 2006 20-6
[PubMed: 16260778]
http://dx.doi.org/10.1074/jbc.M510157200
|
|
Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Samara R, Espinoza LA, Hassa PO, Hottiger MO, Smulson ME.
PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase.
Oncogene 22 2003 8460-71
[PubMed: 14627987]
http://dx.doi.org/10.1038/sj.onc.1206897
|
|
Zhang X, Morera S, Bates PA, Whitehead PC, Coffer AI, Hainbucher K, Nash RA, Sternberg MJ, Lindahl T, Freemont PS.
Structure of an XRCC1 BRCT domain: a new protein-protein interaction module.
EMBO J. 17 1998 6404-11
[PubMed: 9799248]
http://dx.doi.org/10.1093/emboj/17.21.6404
|
|
Tischkowitz M, Hamel N, Carvalho MA, Birrane G, Soni A, van Beers EH, Joosse SA, Wong N, Novak D, Quenneville LA, Grist SA; kConFab, Nederlof PM, Goldgar DE, Tavtigian SV, Monteiro AN, Ladias JA, Foulkes WD.
Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
Eur. J. Hum. Genet. 16 2008 820-32
[PubMed: 18285836]
http://dx.doi.org/10.1038/ejhg.2008.13
|
|
Williams RS, Lee MS, Hau DD, Glover JN.
Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
Nat. Struct. Mol. Biol. 11 2004 519-25
[PubMed: 15133503]
http://dx.doi.org/10.1038/nsmb776
|
|
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res. 25 1997 3389-402
[PubMed: 9254694]
http://dx.doi.org/10.1093/nar/25.17.3389
|
|
Callebaut I, Mornon JP.
From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair.
FEBS Lett. 400 1997 25-30
[PubMed: 9000507]
http://dx.doi.org/10.1016/S0014-5793(96)01312-9
|
|
Shen Y, Tong L.
Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1.
Biochemistry 47 2008 5767-73
[PubMed: 18452305]
http://dx.doi.org/10.1021/bi800314m
|
|
Clapperton JA, Manke IA, Lowery DM, Ho T, Haire LF, Yaffe MB, Smerdon SJ.
Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
Nat. Struct. Mol. Biol. 11 2004 512-8
[PubMed: 15133502]
http://dx.doi.org/10.1038/nsmb775
|
|
Koonin EV, Altschul SF, Bork P.
BRCA1 protein products ... Functional motifs...
Nat. Genet. 13 1996 266-8
[PubMed: 8673121]
http://dx.doi.org/10.1038/ng0796-266
|
|
Du LL, Moser BA, Russell P.
Homo-oligomerization is the essential function of the tandem BRCT domains in the checkpoint protein Crb2.
J. Biol. Chem. 279 2004 38409-14
[PubMed: 15229228]
http://dx.doi.org/10.1074/jbc.M403326200
|
|
Varma AK, Brown RS, Birrane G, Ladias JA.
Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex.
Biochemistry 44 2005 10941-6
[PubMed: 16101277]
http://dx.doi.org/10.1021/bi0509651
|
|
Schmidt U, Wollmann Y, Franke C, Grosse F, Saluz HP, Hanel F.
Characterization of the interaction between the human DNA topoisomerase IIbeta-binding protein 1 (TopBP1) and the cell division cycle 45 (Cdc45) protein.
Biochem. J. 409 2008 169-77
[PubMed: 17887956]
http://dx.doi.org/10.1042/BJ20070872
|
|
Moreau K, Dizin E, Ray H, Luquain C, Lefai E, Foufelle F, Billaud M, Lenoir GM, Venezia ND.
BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase.
J. Biol. Chem. 281 2006 3172-81
[PubMed: 16326698]
http://dx.doi.org/10.1074/jbc.M504652200
|
|